HEADER GENE REGULATION/INHIBITOR 07-JAN-21 7LAZ TITLE CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN (BD1) OF HUMAN BRD3 BOUND TITLE 2 TO ERK5-IN-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RING3-LIKE PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD3, KIAA0043, RING3L; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BET, ERK5, DUAL BRD-KINASE INHIBITOR, GENE REGULATION, GENE KEYWDS 2 REGULATION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.R.KARIM,M.J.BIKOWITZ,E.SCHONBRUNN REVDAT 4 18-OCT-23 7LAZ 1 REMARK REVDAT 3 24-NOV-21 7LAZ 1 JRNL REVDAT 2 17-NOV-21 7LAZ 1 JRNL REVDAT 1 14-JUL-21 7LAZ 0 JRNL AUTH R.M.KARIM,M.J.BIKOWITZ,A.CHAN,J.Y.ZHU,D.GRASSIE,A.BECKER, JRNL AUTH 2 N.BERNDT,S.GUNAWAN,N.J.LAWRENCE,E.SCHONBRUNN JRNL TITL DIFFERENTIAL BET BROMODOMAIN INHIBITION BY JRNL TITL 2 DIHYDROPTERIDINONE AND PYRIMIDODIAZEPINONE KINASE JRNL TITL 3 INHIBITORS. JRNL REF J.MED.CHEM. V. 64 15772 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34710325 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01096 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.71 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 18789 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1128 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.7100 - 4.6020 1.00 2370 152 0.1774 0.2146 REMARK 3 2 4.6020 - 3.6534 1.00 2239 143 0.1500 0.1811 REMARK 3 3 3.6534 - 3.1918 1.00 2214 141 0.2034 0.2295 REMARK 3 4 3.1918 - 2.9000 1.00 2181 139 0.2406 0.2954 REMARK 3 5 2.9000 - 2.6922 1.00 2171 139 0.2577 0.2998 REMARK 3 6 2.6922 - 2.5335 1.00 2175 139 0.2571 0.2830 REMARK 3 7 2.5335 - 2.4067 1.00 2145 136 0.2476 0.3304 REMARK 3 8 2.4067 - 2.3020 1.00 2166 139 0.2312 0.2849 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 19.4344 3.3541 8.4594 REMARK 3 T TENSOR REMARK 3 T11: 0.2713 T22: 0.2596 REMARK 3 T33: 0.2937 T12: 0.0032 REMARK 3 T13: -0.0311 T23: 0.0845 REMARK 3 L TENSOR REMARK 3 L11: 1.9950 L22: 0.7925 REMARK 3 L33: 1.7339 L12: 0.2079 REMARK 3 L13: -0.5473 L23: -0.0197 REMARK 3 S TENSOR REMARK 3 S11: -0.0175 S12: 0.0860 S13: -0.0069 REMARK 3 S21: -0.0018 S22: 0.0949 S23: 0.0888 REMARK 3 S31: -0.0090 S32: -0.0586 S33: -0.0784 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LAZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000253636. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-MAR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18845 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.90 REMARK 200 R MERGE (I) : 0.11100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.30 REMARK 200 R MERGE FOR SHELL (I) : 0.80500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7LAY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 4.3 M SODIUM REMARK 280 CHLORIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.12100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 40.95150 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 40.95150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.06050 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 40.95150 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 40.95150 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 90.18150 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 40.95150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.95150 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 30.06050 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 40.95150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.95150 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 90.18150 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 60.12100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 22 REMARK 465 MET A 23 REMARK 465 PRO A 24 REMARK 465 GLU A 143 REMARK 465 GLU A 144 REMARK 465 SER B 22 REMARK 465 MET B 23 REMARK 465 PRO B 24 REMARK 465 GLU B 143 REMARK 465 GLU B 144 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 69 73.52 56.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VYJ A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VYJ B 201 DBREF 7LAZ A 24 144 UNP Q15059 BRD3_HUMAN 24 144 DBREF 7LAZ B 24 144 UNP Q15059 BRD3_HUMAN 24 144 SEQADV 7LAZ SER A 22 UNP Q15059 EXPRESSION TAG SEQADV 7LAZ MET A 23 UNP Q15059 EXPRESSION TAG SEQADV 7LAZ SER B 22 UNP Q15059 EXPRESSION TAG SEQADV 7LAZ MET B 23 UNP Q15059 EXPRESSION TAG SEQRES 1 A 123 SER MET PRO GLU VAL SER ASN PRO SER LYS PRO GLY ARG SEQRES 2 A 123 LYS THR ASN GLN LEU GLN TYR MET GLN ASN VAL VAL VAL SEQRES 3 A 123 LYS THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE TYR SEQRES 4 A 123 GLN PRO VAL ASP ALA ILE LYS LEU ASN LEU PRO ASP TYR SEQRES 5 A 123 HIS LYS ILE ILE LYS ASN PRO MET ASP MET GLY THR ILE SEQRES 6 A 123 LYS LYS ARG LEU GLU ASN ASN TYR TYR TRP SER ALA SER SEQRES 7 A 123 GLU CYS MET GLN ASP PHE ASN THR MET PHE THR ASN CYS SEQRES 8 A 123 TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL LEU MET SEQRES 9 A 123 ALA GLN ALA LEU GLU LYS ILE PHE LEU GLN LYS VAL ALA SEQRES 10 A 123 GLN MET PRO GLN GLU GLU SEQRES 1 B 123 SER MET PRO GLU VAL SER ASN PRO SER LYS PRO GLY ARG SEQRES 2 B 123 LYS THR ASN GLN LEU GLN TYR MET GLN ASN VAL VAL VAL SEQRES 3 B 123 LYS THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE TYR SEQRES 4 B 123 GLN PRO VAL ASP ALA ILE LYS LEU ASN LEU PRO ASP TYR SEQRES 5 B 123 HIS LYS ILE ILE LYS ASN PRO MET ASP MET GLY THR ILE SEQRES 6 B 123 LYS LYS ARG LEU GLU ASN ASN TYR TYR TRP SER ALA SER SEQRES 7 B 123 GLU CYS MET GLN ASP PHE ASN THR MET PHE THR ASN CYS SEQRES 8 B 123 TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL LEU MET SEQRES 9 B 123 ALA GLN ALA LEU GLU LYS ILE PHE LEU GLN LYS VAL ALA SEQRES 10 B 123 GLN MET PRO GLN GLU GLU HET VYJ A 201 47 HET VYJ B 201 47 HETNAM VYJ 11-CYCLOPENTYL-2-({2-ETHOXY-4-[4-(4-METHYLPIPERAZIN-1- HETNAM 2 VYJ YL)PIPERIDINE-1-CARBONYL]PHENYL}AMINO)-5-METHYL-5,11- HETNAM 3 VYJ DIHYDRO-6H-PYRIMIDO[4,5-B][1,4]BENZODIAZEPIN-6-ONE FORMUL 3 VYJ 2(C36 H46 N8 O3) FORMUL 5 HOH *45(H2 O) HELIX 1 AA1 THR A 36 VAL A 45 1 10 HELIX 2 AA2 VAL A 45 LYS A 52 1 8 HELIX 3 AA3 ALA A 56 TYR A 60 5 5 HELIX 4 AA4 ASP A 72 ILE A 77 1 6 HELIX 5 AA5 ASP A 82 ASN A 92 1 11 HELIX 6 AA6 SER A 97 ASN A 116 1 20 HELIX 7 AA7 ASP A 120 ALA A 138 1 19 HELIX 8 AA8 THR B 36 VAL B 45 1 10 HELIX 9 AA9 VAL B 45 HIS B 53 1 9 HELIX 10 AB1 ALA B 56 TYR B 60 5 5 HELIX 11 AB2 ASP B 64 ASN B 69 1 6 HELIX 12 AB3 ASP B 72 ILE B 77 1 6 HELIX 13 AB4 ASP B 82 ASN B 92 1 11 HELIX 14 AB5 SER B 97 ASN B 116 1 20 HELIX 15 AB6 ASP B 120 GLN B 139 1 20 SITE 1 AC1 6 TRP A 57 PRO A 58 PHE A 59 ASN A 116 SITE 2 AC1 6 HOH A 304 ASN B 69 SITE 1 AC2 12 HIS A 53 GLN A 54 PHE A 55 LYS A 78 SITE 2 AC2 12 TRP B 57 PRO B 58 GLN B 61 LEU B 68 SITE 3 AC2 12 ASN B 116 ILE B 122 HOH B 303 HOH B 306 CRYST1 81.903 81.903 120.242 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012210 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012210 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008317 0.00000